The virulence plasmids of Salmonella typhimurium and other invasive Salmonella serovars have long been associated with the ability of these bacteria to cause systemic infection beyond the intestines in orally inoculated animals. Genetic analysis of virulence genes on the high-molecular-weight plasmids has revealed that no more than five genes spanning a 6.2-kb region are sufficient to replace the entire plasmid for conferring virulence. However, the exact virulence function(s) encoded by these genes has not been elucidated. In this report, we measured the possible effect of the virulence plasmid on the growth rate of S. typhimurium in mice by two complementary procedures. The first procedure used segregation of a temperature-sensitive plasmid in vivo to provide a measure of bacterial divisions and the number of recovered marker plasmid-containing salmonellae as a measure of killing. In the second procedure, aroA deletions were transduced into virulence plasmidcontaining and plasmid-cured S. typhimurium. Since AroA-salmonellae are inhibited for growth in vivo, if the virulence plasmid affected only growth rate, no difference in the recoveries of the paired AroA-strains would be seen. Virulence plasmid-containing S. typhimurium segregated the marker plasmid more rapidly than did the virulence plasmid-cured strain, and AroA-derivatives of both strains were recovered equally from mice. Therefore, the S. typhimurium virulence plasmid increased growth rate but had no detectable effect on killing or bacterial movement into deep tissues. To examine whether the plasmid accomplished this function by affecting the intracellular/extracellular location of bacteria, orally infected mice were injected with gentamicin to kill the extracellular bacteria. Wild-type and plasmid-cured S. typhimurium strains were equally resistant to gentamicin in vivo and hence most likely located intracellularly to equal degrees. When wild-type and plasmid-cured S. typhimurium strains were sequestered within peritoneal chambers in mice, the resulting extracellular growth was equal. Therefore, the virulence plasmid increases the growth rate of S. typhimurium in mice, probably within mouse cells.
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Salmonella typhimuiium and other Salmonella serovars cause self-limiting gastroenteritis in the healthy human population. However, in immunocompromised patients such as those with AIDS (5, 12, 13, 33) or with certain cancers undergoing chemotherapy (3, 6, 23, 37) , a more invasive infection, i.e., bacteremia, which can be life threatening, results. The Salmonella serovars with invasive potential possess genetically related high-molecular-weight virulence plasmids (14) , and a higher percentage of invasive clinical isolates of S. typhimunium and Salmonella enteritidis carries the virulence plasmid than noninvasive isolates (29) . In a mouse model of oral infection, the recovery of S. typhimurium from the mesenteric lymph nodes and spleens is dependent on the presence of the virulence plasmid (17) . The plasmid is not necessary for infection of the intestines, resistance to complement-mediated bacteriolysis of serum, resistance to phagocytosis and killing by macrophages, or adherence to, invasion into, and growth within certain cell lincs (17) . The way that the plasmid affects the spread of the infection to deep tissues has not been determined.
The number of bacteria recovered from a tissue of an infected animal is affected by three components: (i) the rate of killing by the host, (ii) the rate of movement of the bacteria into and out of the tissue, and (iii) the growth rate of the bacteria. Because virulence plasmid-containing salmonellae are recovered in greater numbers from lymphoid tissues than are isogenic plasmid-cured strains, many have * Corresponding author.
hypothesized that the plasmid affects resistance to macrophages or growth within these cells; however, no data supporting these hypotheses have been published.
In this study, we have examined the growth rates of wild-type and virulence plasmid-cured S. typhimurium strains in a mouse model of infection by using procedures developed by Benjamin et al. and Fallon et al. (1, 11) . The use of a temperature-sensitive (ts) genetic marker to measure the relative number of bacterial cell divisions indicated that wild-type S. typhimurium grew more rapidly in vivo than virulence plasmid-cured S. typhimurium but was killed and moved through tissues at rates equal to those of the virulence plasmid-cured strain. This finding was confirmed by using wild-type and plasmid-cured salmonellae with an aroA deletion inhibiting growth in vivo. Essentially all bacteria of both strains were gentamicin resistant in mice by day 4 postinoculation, and extracellular growth of the two strains in mice was equal. Therefore, the virulence plasmid functions to increase the growth rate of S. typhimurium, most likely within the host cells of mice.
(A preliminary report of these results has been presented previously [20] .)
MATERIALS AND METHODS
Bacterial strains and culture. Bacteria were grown in L broth or L agar (28) supplemented with antibiotics at the plasmid-containing S. typhimunum SR-11 x3456 and X3181 and isogenic virulence plasmid-cured X33337 have been described (17) . The AaroA mutation of S. typhimunum WB266 was transduced into X3181 and X3337 by using the linked zbj-465::TnlO insertion (11) by P22HTint-mediated generalized transduction as described previously (32) . Transductants were selected on tetracycline and screened for the AroA-phenotype (Tyr-Trp-Phe-, para-amino benzoic acid requiring). The AaroA derivatives of X3181 and X3337
were named UFO20 and UFO21, respectively. To verify that any phenotype associated with UF020 and UF021 was due to the AaroA, the wild-type aroA gene was transduced back into UFO20 and UF021 from S. typhimunium X3000 (17) , selecting for Tcr and prototrophy. The AroA+ wild-type transductants were named UF025 and UF026 for the virulence plasmid-containing and cured strains, respectively.
Infection of mice. Mice were orally inoculated with S. typhimunum as described previously (16) . Approximately 2 x 108 CFU of S. typhimunum was fed to 7-to 11-week-old female BALB/c mice (Charles River, Wilmington, Mass.) after food and water deprivation and feeding of bicarbonate. Five days later, Peyer's patches, mesenteric lymph nodes, and spleens were removed, homogenized in glass tissue homogenizers with phosphate-buffered saline containing gelatin (BSG) (8) , and plated to enumerate CFU. Additionally, the hind footpads of the mice were inoculated subcutaneously as described previously (31) . Approximately 105 CFU of salmonellae suspended in 0.05 ml of BSG was injected into the hind footpads of the mice. Three days later, popliteal lymph nodes and spleens were removed, homogenized in BSG, and plated to enumerate CFU.
Use of plasmid pHSG422 to measure growth rate of salmonellae in mice. To examine the relative growth rates of wild-type and virulence plasmid-cured S. typhimurium strains in mice, we used a modification of the procedure of Benjamin et al. (1) . Wild-type S. typhimurium x3456 and virulence plasmid-cured X3337 were transformed with the ts Cmr plasmid pHSG422 (21) . Maintenance of the plasmid during growth at 30°C and loss of the plasmid during growth at 37°C were confirmed by growth in vitro in L broth. The segregation kinetics of pHSG422 from x3456 and X3337
were essentially the same. For inoculation of mice, x3456 (pHSG422) and X3337(pHSG422) were grown statically overnight at 30°C in L broth containing chloramphenicol. The next day, these cultures were diluted 1:20 into fresh 37°C L broth without antibiotic and shaken at 37°C for approximately 2 h until the cultures reached an optical density at 600 nm of approximately 0.5. The percentage of each strain maintaining pHSG422 and the total number of pHSG422 plasmids in each culture were determined as described previously (1). The 2-h incubation period at 37°C resulted in approximately 75% of each strain maintaining the plasmid with a copy number of one or two plasmids per cell. The bacterial cultures were pelleted at 37°C by centrifugation and suspended in prewarmed BSG at 37°C for oral inoculation into mice at 2 x 108 CFU per mouse. Mice were housed at room temperature. Five days later, mice were killed, and tissues were homogenized and plated on media either containing or not containing chloramphenicol. The proportion of bacteria maintaining pHSG422 was determined by calculating the difference in the log1o total CFU and the log10 CFU carrying pHSG422. This proportion is expressed as the log1o.
Use of gentamicin to kill extracellular bacteria. Examining the extracellular/intracellular nature of salmonellae was done by killing extracellular bacteria in mice by injection of gentamicin as described previously (9) Peritoneal chamber implants. Salmonellae were grown in the peritoneal cavities of mice by using peritoneal chambers as described previously (7) . Pharmaceutical-grade in-line syringe filters (0.22-,um pore size, 8-mm wide; Filtertek Inc., Hebron, Ill.) were kindly provided by K. D. Coleman. The male and female ends of separate filters were removed, the male end of one filter was filled with 0.05 ml of salmonellae suspended in BSG, and the corresponding female end was glued into place with Krazy Glue (Krazy Glue, New York, N.Y.). Mice were anesthetized by intraperitoneal injection of 1 mg of pentobarbital sodium (Nembutal; Abbott Laboratories, North Chicago, Ill.). The abdomens were shaved and disinfected, a 1-cm incision was made in each abdominal wall, and then a 1-cm incision was made in each peritoneum. The sealed chambers were placed into the peritoneal cavities, the peritoneums were closed with two sutures, and the abdominal walls were each sealed with two surgical clips (9-mm length, Autoclips; Clay Adams, Parsippany, N.J.). The mice were observed for 2 days, at which time they were killed, the chambers were removed, and the contents were diluted and plated on agar media containing appropriate antibiotics. Peritoneal cavities were tested for leakage of bacteria from the chamber by swabbing and plating on L agar. No leakage was detected.
Statistical analysis. Analysis of CFU using log1o CFU was performed as described previously (4) . For a comparison of mean CFU between groups of mice inoculated with single salmonella strains, the Student t test was used for analysis of the log1o CFU to determine whether there was a significant difference between the means found for plasmid-containing and plasmid-cured strains. In experiments in which individual mice were inoculated with two strains, the mean paired difference in the log1o CFU was determined by using a paired Student t test. In some cases, results from two or three experiments were pooled for analysis.
RESULTS
Rationale for determination of in vivo growth rate. Wildtype S. typhimunium is recovered in higher numbers than the isogenic plasmid-cured derivative from the mesenteric lymph nodes and spleens of orally inoculated mice (17) . This difference in infectivity can be the product of the three independent factors, i.e., relative rates of growth, killing, and movement of the two strains in mouse tissues. To measure the growth rate in vivo in mice independently of the other two factors, we used an unstable genetic element which would be lost with each bacterial division in vivo. The genetic element, plasmid pHSG422, is extremely ts for replication at 37°C (21) and therefore is lost from a portion of the bacterial population with each division in mice (1, 11 (11) . The ability of salmonellae to grow in vivo was inhibited by transducing into the bacteria a deletion of the aroA gene. AroA-salmonellae require the aromatic amino acids, cannot make the siderophore enterobactin, and require paraamino benzoic acid for growth (25) . The amino acids are probably supplied by the host, and it has been reported that enterobactin is not required for infectivity of S. typhimurium (2) . The major defect of AroA-strains is probably the requirement for para-amino benzoic acid, which cannot be supplied by the host in sufficient amounts, resulting in a deficiency in replication (1) One set of mice was orally inoculated with both strains of AroA+ S. typhimurium: plasmid-positive UF025 and plasmid-negative UF026. A second set of mice was inoculated with both strains of AroA-S. typhimurium: plasmid-positive UFO20 and plasmid-negative UFO21. The paired differences in the log CFU of the two strains recovered from tissues were compared for mice infected with wild-type and plasmid-cured salmonellae (Table 3) . Since all strains were Tcr and only plasmid-cured UFO21 and UF026 were Nalr, the CFU of UFO20 and UF025 were calculated as Tcr CFU minus Nalr CFU and by replica-plating Tcr CFU to nalidixic acid plates. As is usually seen for AroA+ strains, equal numbers of CFU were found in the Peyer's patches (P > 0.25), whereas 8-and 32-fold more virulence plasmid-containing UF025 than plasmid-cured UF026 was recovered from the mesenteric lymph nodes (P < 0.0005) and spleens (P <0.0005), respectively.
A different result was obtained with the AroA-derivatives. Because of the inhibited replication of each strain, grossly lower numbers of CFU were recovered from all tissues, especially the mesenteric lymph nodes and spleens. The recovery of CFU from the spleen was too low for statistical analysis. However, the mean paired differences in Three days later, popliteal lymph nodes and spleens were examined for CFU as described in Table 3 , footnote a. These are the results of two experiments.
the log CFU of wild-type and virulence plasmid-cured salmonellae in all of the other tissues were not significantly different. Therefore, the inhibition of replication by AaroA removed all measurable differences in the infectivities of wild-type S. typhimurium relative to the isogenic virulence plasmid-cured derivative, indicating that the increased growth rate of wild-type salmonellae was the major reason for the increased recovery of wild-type over plasmid-cured salmonellae from mesenteric lymph nodes and spleens.
Because of problems in recovering enough AroA-salmonellae from deep tissues after oral inoculation, we studied the effect of the AaroA mutation by using a subcutaneous injection into the hind footpads (Table 4) . It has been reported that wild-type and cured S. typhimunum strains equally invade the draining popliteal lymph nodes, while the virulence plasmid-containing strain is more efficient at invading spleens (31) . AroA+ virulence plasmid-containing UF025 infected the popliteal lymph nodes slightly more effectively (1.6 fold) than did AroA+ plasmid-cured UF026 (P < 0.05), whereas UF025 achieved 25-fold higher splenic CFU relative to UF026 (P < 0.0005). However, the AroA-derivatives UFO20 and UFO21 equally infected both the popliteal lymph nodes and spleens, again demonstrating that the inhibition of the replicative potential of S. typhimurium by AaroA fully eliminated the virulence plasmid phenotype of invasive infection to deep tissues.
Virulence plasmid-containing and plasmid-cured S. typhimurium strains are most likely intracellular after oral inoculation. Since S. typhimurium is capable of intracellular as well as extracellular infection, it was possible that the virulence plasmid affected the growth rate by altering the intracellular/extracellular location of salmonellae. To compare the intracellular/extracellular environment of wild-type and plasmid-cured salmonellae in orally inoculated mice, we used the procedure of Dunlap et al. (9) in which gentamicin is administered to mice to kill extracellular, but not intracellular, salmonellae. Mice were orally inoculated with mixtures of wild-type x3456 and plasmid-cured X3337. At various times after inoculation, mice were injected with gentamicin, and the yields of gentamicin-resistant CFU of each strain were examined (Table 5) .
At (9), essentially all S. typhimurium strains in all tissues examined after oral inoculation of mice were gentamicin resistant and probably intracellular. Since the presence or absence of the virulence plasmid did not affect gentamicin resistance, the plasmid probably did not alter the intracellular/extracellular location of the bacteria. The increased growth rate identified above for wild-type salmonellae most likely occurs within cells of the mice.
The virulence plasmid does not affect growth of extracellular salmonellae in mice. A converse hypothesis to the virulence plasmid affecting the intracellular growth rate of S. typhimurium is that extracellular growth rates in mice inoculated with wild-type and plasmid-cured salmonellae would be equal. To examine this possibility in vivo, wild-type x3456 and plasmid-cured X3337 were placed within chambers and implanted into the peritoneal cavities of separate mice. The chambers were sealed with 0.22-,um-pore-size filters which prevent the escape of bacteria and the entry of host cells; however, diffusion of solutes can occur, enabling bacterial growth in the extracellular environment of the peritoneal cavity (7). Two days after mice were surgically a Groups of four mice were inoculated orally with mixtures of 10i CFU each of wild-type x3456 and plasmid-cured X3337. On day 4 postinoculation, one set of mice (Gent 24h) received two intraperitoneal injections of 0.1 mg of gentamicin and then 0.1 mg intravenously on day 5 postinoculation. Forty-five minutes later, tissues were sampled for CFU of X3456 and X3337. On day 5, a second set of mice was given a single dose of 0.1 mg of gentamicin intravenously 45 min before the tissues were sampled (Gent 45m). A third set of mice received no gentamicin before the tissues were sampled on day 5 (-Gent).
b The mean paired differences in log CFU X3456-X3337 were examined for values different than 0.
INFECT. IMMUN. implanted with peritoneal chambers containing 105 CFU of either X3456 or X3337 per ml, the strains grew to equal yields (8.8 ± 0.06 and 9.2 ± 0.47 log CFU, respectively; P > 0.1). In a pilot experiment, the yields of the two strains were equal from day 1 to 3 postimplantation (data not shown). Therefore, the virulence plasmid did not affect the growth of S.
typhimurium in mice when bacteria were sequestered extracellularly.
The spv genes are sufficient to confer an increased growth rate. All of the experiments described above examined the effect of the presence or absence of the entire virulence plasmid on the growth rate in mice. We (15) and others (26, 36) have described an approximately 8-kb region of the virulence plasmid encoding the essential virulence genes.
We constructed plasmid pGTRO61 encoding the five spv virulence genes and an additional open reading frame, orfE (15) . pGTRO61 could replace the entire virulence plasmid of S. typhimunium to confer splenic infection and oral 50% lethal dose (LD50). We therefore examined whether this virulence region subclone would similarly confer the increased growth rate observed with the entire virulence plasmid. pGTRO61 and its vector, pYA2204, were transformed into virulence plasmid-cured S. typhimunum X3337. Since pYA2204 and pGTRO61 encode Apr, also encoded on pHSG422, we deleted the Apr gene from pHSG422, yielding pGTR253. The ts phenotype of pGTR253 was identical to that of pHSG422 (data not shown). Mice were orally inoculated with either X3337(pGTR061/pGTR253) or X3337(pYA2204/ pGTR253). Five days later, 98-fold-more pGTRO61-containing salmonellae than vector controls were recovered from spleens (P < 0.0005); however, the numbers of pGTR253-containing bacteria of each strain were not significantly different (Table 6 ). X3337(pGTR061) segregated the ts marker to about 1/150th of the vector construct (P < 0.0005), indicating that, as was observed for the entire virulence plasmid, the spv genes alone were sufficient to confer an increased growth rate in vivo. Similar results were obtained in a repetition of this experiment.
DISCUSSION
It is well established that the virulence plasmid of S. typhimurium is involved in the ability of salmonellae to invade from the intestines into deeper tissues, such as the mesenteric lymph nodes and spleens, after oral inoculation of mice (14) . Although an understanding of the genetic organization of the essential virulence genes and their regulation has emerged (19) , the virulence functions resulting in infectivity in areas beyond the intestines have heretofore not been elucidated. Several groups have hypothesized that the plasmid affects intracellular killing by macrophages or growth within macrophages, although no definitive data have ever been published. By using a variety of techniques involving the mouse model of infection, we show that the virulence plasmid increases the growth rate of S. typhimurium most likely within as-of-yet-unidentified host cells of mice. The major experimental problem was to separate the roles of the rates of killing, movement, and growth in vivo. This was initially done by using an unstable genetic element, the plasmid pHSG422, to measure the bacterial cell divisions occurring in vivo. This procedure was pioneered by William Benjamin and David Briles to show that the major effect of the Itys genotype in mice is to permit an increased growth rate of S. typhimunum (1) and that S. typhimurium grows more slowly in mice infected with murine hepatitis virus (11) .
In our studies, wild-type S. typhimunium X3456 segregated the marker pHSG422 more rapidly in tissues of mice which yielded higher numbers of x3456 than virulence plasmidcured X3337 (Table 2 ). The necessary conclusion from these data is that x3456 underwent more divisions in the mice because of a more rapid growth rate. Analysis of the total CFU of each strain carrying the marker also allowed us to conclude that equal rates of killing and movement occurred for the strains. Equal numbers of CFU of wild-type and virulence plasmid-cured S. typhimurium possessed pHSG422. If X33337 were killed more efficiently in mice than x3456, fewer pHSG422-containing CFU would have been recovered because once a pHSG422-containing cell is killed, it cannot be replaced with another pHSG422-containing cell.
Similarly, if X3337 had moved less efficiently, fewer pHSG422-containing bacteria would have been recovered from deeper tissues.
A complementary procedure was used to more specifically examine the possibilities that rates of killing and movement of bacteria were responsible for the differences in yields of wild-type and plasmid-cured salmonellae from mesenteric lymph nodes and spleens. Both strains were endowed with deletions of the aroA gene, rendering the strains defective for replication in mice (1, 11, 25) . We found that replicationdefective plasmid-containing and plasmid-cured S. typhimunum strains were now equal in their infectivities for mesenteric lymph nodes and spleens. Had the plasmid-cured salmonellae been more susceptible to killing by the mice, they would have been recovered in numbers lower than those of the wild-type strain. Similarly, as long as the aroA deletion itself did not affect the movement of bacteria through tissues, increased movement caused by the virulence plasmid would have resulted in a lower recovery of the plasmid-cured strain from deeper tissues. However, by restricting the growth of plasmid-containing and plasmidcured S. typhimurium strains to what is assumed to be equal rates of near zero, the virulences of the two strains were made equal. It therefore appeared that different rates of killing or movement were not responsible for different recoveries of plasmid-containing and plasmid-cured salmonellae from mesenteric lymph nodes and spleens.
To begin to understand where the virulence plasmid affected growth rate, we examined the intracellular/extracellular nature of the bacteria in mice by using a procedure developed by Dunlap et al. (9) involving the use of gentamicin to kill extracellular bacteria. Gentamicin is commonly used in tissue culture to kill extracellular bacteria since this antibiotic is not effective intracellularly (17) . We found that gentamicin treatment of salmonella-infected mice for as long as 24 h before enumeration of CFU in tissues had no effect A corollary hypothesis to one of different intracellular growth rates is that extracellular growth rates of wild-type and plasmid-cured salmonellae would be equal. We previously showed that the virulence plasmid did not affect the ability of S. typhimurium to grow in heat-treated serum or to be resistant to killing by complement (17) . Therefore, different extracellular growth rates were not expected. Salmonellae were sequestered in an extracellular environment in the peritoneal cavities of mice by using growth chambers sealed with 0.22-,um-pore-size filters (7). When plasmid-containing and plasmid-cured S. typhimurium strains were inoculated at 105 CFU into the chambers in the peritoneal cavities of mice, increases in CFU higher than 1,000-fold occurred for both strains. The plasmid therefore did not affect the extracellular growth of S. typhimurium in mice, as modeled by the peritoneal chamber implants.
We have not identified the putative host cell in which the wild-type salmonellae replicate more rapidly than the plasmid-cured derivative. We hypothesize several mechanisms by which the plasmid may increase the intracellular growth rate in vivo. First, the plasmid may enable S. typhimunium to seek out an environment more permissive for growth. Examples of mechanisms include altering the specificity for infection of host cells, altering the intracellular location of salmonellae within host cells, or affecting the response of host cells to infection by S. typhimunium. Alternatively, the virulence plasmid may enable S. typhimunium to replicate more rapidly in a given environment of the appropriate host cell.
Our results that a subclone, pGTRO61 (15) , encoding the five virulence genes spvRABCD, conferred an increased growth rate to virulence plasmid-cured S. typhimurium X3337 (Table 6 ) raise questions as to the role of other potential virulence loci of the virulence plasmid (22, 27, 30, 34, 35) . Some loci have been identified solely through cloning (22, 35) , while others have been identified solely through mutagenesis (27, 34) . We previously showed that pGTRO61 could replace the entire virulence plasmid to confer wild-type splenic infection and LD50 after oral inoculation of mice (15) , raising the question of other virulence genes on the plasmid.
Hoertt et al. (24) reported that virulence plasmid-containing S. typhimurium caused immunosuppression in mice. Most recently, Emoto et al. (10) reported that wild-type Salmonella choleraesuis failed to elicit -y/l T cells to the peritoneal cavity after intraperitoneal inoculation, in contrast to the isogenic virulence plasmid-cured strain which did elicit the T cells. This is an intriguing result; however, no direct linkage between the virulence plasmid and failure to elicit y/y T cells can be drawn since other types of attenuated salmonellae were not examined. Although the data presently reported do not address possible immunosuppression, should plasmid-mediated immunosuppression occur in orally inoculated mice, it would have to result in an altered growth rate, as opposed to killing, of salmonellae. It should be noted that the plasmid does not affect system-wide responses of mice to salmonella infection since wild-type bacteria are incapable of helping plasmid-cured salmonellae, and, conversely, infection with plasmid-cured salmonellae does not hinder the infection by wild-type salmonellae (17) . Immunosuppression would therefore have to act at the level of salmonellae interacting with individual host cells. This situation seems to be inconsistent with the results of Emoto et al. (10) . In any case, we can now focus attention on a limited set of virulence genes, spvRABCD, encoding a defined phenotype of increased growth rate in mice.
